17,261 trials
Hypercholesterolemia
Primary: Percent Change in LDL-C From Baseline for Rosuvastatin 5mg Daily Compared With Placebo and Each Dietary Supplement. — -37.86; -2.63; -3.43; 0.42 percent change LDL-C…
Type1 Diabetes Mellitus
Primary: Change in Average Daily Total Insulin Use — -6.72; -5.25; -1.37; -7.59 Units/day
Sturge-Weber Syndrome
Primary: List Sorting Working Memory Test — 37.14; 39.14 T-score
Pain
Primary: Evaluation of Pain Intensity - Mean Pain Score During Procedure — 3.03; 3.10; 4.25 units on a scale
Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Fatty Liver · Non-Alcoholic Steatohepatitis
Primary: Change in Hepatic Fat Fraction [%] Between of Vitamin E and DHA EE vs Placebo — -6.8; -8.2 Percentage of liver fat
Nicotine Dependence
Primary: Mean Number of Conventional Cigarettes Smoked During Each Switch Week — 3.2; 3.2; 5.8; 3.1 Cigarettes per day
Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells
Primary: Number of Participants Experiencing Adverse Events Incidence With of Salicylate + Venetoclax + Decitabine — 1 Participants
Acute Decompensated Heart Failure
Primary: Change in E/Ea Ratio — -4.55; -1.55; -3.16; -1.08 Unitless ratio — p=0.029
Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
Primary: Number of Participants With a Response — 0; 8; 1; 2 Participants
HIV Infections
Primary: Percentage of Infants Experiencing at Least One Grade 3 or Higher Adverse Event (AE) — 40.0; 46.7 Percentage of participants — p=0.79
Stage II Prostate Adenocarcinoma · Stage III Prostate Adenocarcinoma · Stage IV Prostate Adenocarcinoma
Primary: Sensitivity, Specificity, Positive, and Negative Predictive Value of 68Ga-RM2 PET for the Detection of Regional Nodal Metastases Compared to Pathology at Radical…
Tuberculosis, Multidrug-Resistant
Primary: Time to Sputum Culture Conversion — 5.9; 6.3; 6.1; 6.1 weeks
Carcinoma, Non-Small-Cell Lung
Primary: Disease Control Rate (DCR) After 12 Weeks Induction — 0.742 proportion of participants
Covid19 · Anosmia · Olfactory Disorder
Primary: UPSIT — 59; 43 percentage of participants
Head and Neck Cancer · Squamous Cell Carcinoma
Primary: Change in Tumor Size — 1; 3; 11 Participants